ArticleBMJ open diabetes research & care2015

Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study.

Yumie Takeshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.